Ticagrelor Reversal Agent on the Horizon

10:49 EDT 25 Mar 2019 | Medscape

A reversal agent for the P2Y12 inhibitor may soon be available after results of a new study showed immediate and sustained reversal of the antiplatelet effects of the drug.
Medscape Medical News

Original Article: Ticagrelor Reversal Agent on the Horizon


More From BioPortfolio on "Ticagrelor Reversal Agent on the Horizon"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...